Generated by DeepSeek V3.2| transfer RNA | |
|---|---|
| Name | transfer RNA |
| RNA type | transfer RNA |
| Tax Domain | Eukaryota, Bacteria, Archaea |
transfer RNA. Transfer RNA is a crucial adaptor molecule in the biological synthesis of proteins, acting as the physical link between the genetic code in messenger RNA and the corresponding amino acid. These small, non-coding RNA molecules are transcribed from DNA and undergo extensive post-transcriptional modification before becoming functional. The accurate decoding of genetic information by tRNA is fundamental to the fidelity of protein biosynthesis in all known forms of life, from Escherichia coli to Homo sapiens.
The canonical secondary structure of tRNA resembles a cloverleaf, consisting of four base-paired stems and three characteristic loops. This includes the acceptor stem, which terminates in the sequence CCA tail where the specific amino acid is covalently attached by enzymes called aminoacyl tRNA synthetase. The anticodon loop contains the triplet nucleotide sequence that base-pairs with the complementary codon on messenger RNA during translation. The three-dimensional conformation, first elucidated through X-ray crystallography studies on yeast tRNAPhe, is an L-shaped tertiary structure stabilized by unusual interactions like Hoogsteen base pairing. This compact architecture positions the acceptor stem and the anticodon loop at opposite ends, facilitating its dual function in aminoacylation and ribosome binding. Additional conserved features include the D-loop and the TΨC loop, named for the presence of modified nucleosides like dihydrouridine and pseudouridine.
Transfer RNA genes are transcribed by RNA polymerase III in eukaryotes and by RNA polymerase in prokaryotes like Bacillus subtilis. Initial transcripts, known as precursor tRNAs, often contain extra sequences at both the 5' and 3' ends. Maturation involves the cleavage of these extensions by ribonuclease P and other endoribonuclease enzymes. The ubiquitous 3'-CCA tail is added by the enzyme tRNA nucleotidyltransferase in most organisms, though it is encoded in the genome of some Archaea. A critical step is the extensive chemical modification of specific nucleotide bases, catalyzed by numerous methyltransferase and isomerase enzymes, producing residues such as inosine and queuosine. These modifications are essential for proper folding, stability, and codon recognition fidelity. In mitochondria and chloroplasts, tRNA processing follows distinct pathways involving organelle-specific polymerase and processing enzyme complexes.
Transfer RNAs are classified primarily by the amino acid they carry, leading to at least one distinct tRNA for each of the twenty standard amino acids. However, most cells contain many isoacceptor tRNA species that carry the same amino acid but respond to different codons due to variations in their anticodon sequence. A special class is initiator tRNA, which is used exclusively to start protein synthesis by recognizing the start codon AUG; in bacteria, this molecule is specifically formylated to become fMet-tRNA. Suppressor tRNA are mutant variants that can insert an amino acid at a stop codon, thereby suppressing nonsense mutations. Organisms also possess specialized tRNAs for selenocysteine and pyrrolysine, the 21st and 22nd genetically encoded amino acids. The Wobble hypothesis, proposed by Francis Crick, explains how a single tRNA can recognize multiple codons through flexible pairing at the third nucleotide position.
During the elongation phase of translation, tRNA molecules shuttle amino acids to the ribosome. An aminoacyl-tRNA, charged by its cognate aminoacyl tRNA synthetase, is delivered to the ribosomal A site by the elongation factor EF-Tu in bacteria or eEF1A in eukaryotes. The anticodon-codon pairing is scrutinized by the ribosome, ensuring translational accuracy. Following peptide bond formation catalyzed by peptidyl transferase, the tRNA moves to the P site and finally the E site before being ejected. The ribosome acts as a ribozyme, with the catalytic activity residing in the ribosomal RNA of the large ribosomal subunit. The process is highly conserved across Escherichia coli, Saccharomyces cerevisiae, and Homo sapiens, though details of the initiation and termination factors differ between domains of life.
Mutations in mitochondrial DNA encoding mitochondrial tRNA are linked to severe human diseases such as MELAS syndrome and MERRF syndrome. Defects in nuclear-encoded tRNA processing enzymes, like those involved in CCA addition or modification, can cause neurological disorders; for example, mutations in PUS3 cause intellectual disability. Some aminoglycoside antibiotics, including streptomycin and gentamicin, bind directly to the decoding center of the ribosome and induce misreading by interfering with tRNA-mRNA interactions. Furthermore, alterations in tRNA modification patterns have been observed in various cancer types, influencing protein synthesis rates and cellular metabolism. Research into tRNA-derived fragments suggests they may have roles in gene regulation and as biomarkers for conditions like prostate cancer.
The RNA world hypothesis posits that tRNA molecules are among the most ancient biological polymers, potentially originating from the ligation of smaller RNA hairpins. The high conservation of the CCA tail and the L-shape across all domains of life supports this deep evolutionary ancestry. The discovery of operational RNA codes within the acceptor stem, recognized by aminoacyl tRNA synthetase, suggests an early form of genetic code that predated the anticodon-codon system. Studies on the ribosome from Thermus thermophilus and other extremophiles indicate that the peptidyl transferase center is composed entirely of ribosomal RNA, reinforcing the idea of an ancient RNA-based protein synthesis apparatus. The evolution of the twenty aminoacyl tRNA synthetase enzymes, divided into two distinct Class I and Class II families, provides a genomic record of the expansion and refinement of the genetic code over billions of years.